Rani Therapeutics Holdings, Inc. 8-K

What Happened
Rani Therapeutics Holdings, Inc. announced on March 26, 2026 that it issued a press release providing a corporate update and reporting its financial results for the fourth quarter and year ended December 31, 2025. The press release is furnished as Exhibit 99.1 to the Form 8-K.

Key Details

• Date of disclosure: March 26, 2026.
• Period covered: fourth quarter and full year ended December 31, 2025.
• The company’s press release with the reported results is included as Exhibit 99.1 to the 8-K.
• The Form 8-K was signed by Svai Sanford, Chief Financial Officer, on March 26, 2026.
• The company states the exhibit is furnished (not “filed”) for purposes of Section 18 of the Exchange Act.

Why It Matters
This 8-K notifies investors that Rani has publicly released its latest quarterly and annual financial results and a corporate update; investors should review Exhibit 99.1 (the press release) for the specific financial figures, trends, and management commentary that may affect the company’s outlook and valuation. The filing itself does not add new financial detail beyond furnishing the press release and clarifies the legal status of that disclosure.